Teva Pharmaceutical (TEVA) shows resilience with innovative therapies like Austedo & Ajovy, raising growth potential despite past struggles.

Hallador Energy downgraded to Neutral at B. Riley on valuation after the stock's recent run-up and ahead of any long-term ...

Ready Capital reported another poor quarter with negative distributable earnings. Click here to find out why RC stock is a ...

Discover key insights from 3D Systems' Q2 2025 earnings call, including cost-saving strategies, revenue trends, and growth focus areas like MedTech & Dental.

The Voya Small Company Fund underperformed its benchmark, the Russell 2000 Index (the Index) on a net asset value basis. Read ...

Eli Lilly and Company faces valuation pressure after disappointing Orforglipron results. Discover why now isn't the time to ...

Discover TAT Technologies' Q2 2025 highlights: 18% revenue growth, record 25%+ gross margin, $85M backlog boost.

LINC's post-earnings drop stems from valuation risks and capex concerns, yet labor shortages and education demand highlight ...

APS segment revenue was $507 million, adjusted EBITDA $80 million, and backlog at $1.57 billion, down 10% year-over-year. MTS segment pro forma revenue was $92 million, with adjusted EBITDA of $18 ...

Dynatrace delivered strong Q1 2026 results with 20% revenue growth, robust ARR expansion, and profitability exceeding ...

AIPI executes a covered call strategy on stocks of AI-focused companies. AIPI has 25 stock holdings weighing a bit more than ...

AbbVie (NYSE:ABBV) invests $195M in North Chicago for API production, boosting U.S. pharmaceutical manufacturing. Read more ...